FDA DEVICE FACTS
Parietene Macroporous Mesh
Sofradim Production
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
Parietene™ Macroporous Mesh is indicated for the repair of hernias or other fascial deficiencies that require the addition of a reinforcing material.
Summary comparing the technological characteristics of the subject and predicate device: Parietene™ Macroporous Mesh was initially designed to be used via open or laparoscopic approach. In order to provide the user with information related to trocar compatibility during laparoscopic surgeries of the Parietene™ Macroporous Mesh (K142091) , modifications of the IFU are proposed. It includes minor changes to the IFU which are implemented since clearance of K142091 but did not exceed the threshold for a new 510(k). These modifications have no impact on the substantially equivalence between the subject device and the predicate device in terms of indications and design for the following technological characteristics:
• Indications
• Design
• Raw materials
• Packaging
• Biocompatibility
• Stability
• Sterilization
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。